Irritable bowel syndrome: a little understood organic bowel disease? (Q34150284)

31 July 2017

1 reference

title

Irritable bowel syndrome: a little understood organic bowel disease? (English)

1 reference

31 July 2017

irritable bowel syndrome

1 reference

2

Robin Spiller

1 reference

31 July 2017

Nicholas J Talley

1

1 reference

PubMed ID

12241674

31 July 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

31 July 2017

1 reference

31 July 2017

360

1 reference

31 July 2017

9332

1 reference

31 July 2017

555-564

1 reference

Towards positive diagnosis of the irritable bowel

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Gender differences in irritable bowel symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The impact of irritable bowel syndrome on health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The burden of selected digestive diseases in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Functional somatic syndromes: one or many?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Irritable bowel syndrome and upper dyspepsia among the elderly: a study of symptom clusters in a random 70 year old population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The Clinical Course and Prognostic Determinants of the Irritable Bowel Syndrome: A Literature Review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Irritable bowel syndrome symptom patterns: frequency, duration, and severity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The irritable bowel syndrome: long-term prognosis and the physician-patient interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Antibiotics increase functional abdominal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Intergenerational transmission of gastrointestinal illness behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

A population study on irritable bowel syndrome and mental health

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Psychological factors in functional gastrointestinal disorders: characteristics of the disorder or of the illness behavior?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Predictors of health care seeking for irritable bowel syndrome: a population based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Dysmotility of the small intestine in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Functional abdominal pain, psychiatric illness, and life events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Level of chronic life stress predicts clinical outcome in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

V. Stress and irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Evidence for two distinct perceptual alterations in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Site of pain from the irritable bowel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Regional cerebral activity in normal and pathological perception of visceral pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Cortical processing of human somatic and visceral sensation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Gastric distention correlates with activation of multiple cortical and subcortical regions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Central nervous pathways mediating angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Anticipatory coping of pain expressed in the human anterior cingulate cortex: a positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Pain affect encoded in human anterior cingulate but not somatosensory cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Dissociating pain from its anticipation in the human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Pathobiology of visceral pain: molecular mechanisms and therapeutic implications V. Central nervous system processing of somatic and visceral sensory signals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Proximal colonic response and gastrointestinal transit after high and low fat meals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Abdominal wall muscle activity in irritable bowel syndrome with bloating

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Abnormal colonic fermentation in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Intestinal gas dynamics and tolerance in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Mechanisms of intestinal gas retention in humans: impaired propulsion versus obstructed evacuation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Defaecography in patients with irritable bowel syndrome and healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The geographic hypothesis and lactose malabsorption. A weighing of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Incomplete absorption of the carbohydrate in all-purpose wheat flour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Measurement of starch absorption in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Double blind, placebo controlled food reactions do not correlate to IgE allergy in the diagnosis of staple food related gastrointestinal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The role of psychological and biological factors in postinfective gut dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Effects of inflammatory mediators on gut sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Enterochromaffin and serotonin cells are abnormal for patients with colonic inertia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The irritable bowel syndrome and psychiatric disorders in the community: is there a link?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Emotional abuse, self-blame, and self-silencing in women with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Irritable bowel syndrome and sexual/physical abuse history.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: A preliminary model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Pain from rectal distension in women with irritable bowel syndrome: relationship to sexual abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Familial association in adults with functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

EVIDENCE OF A GENETIC CONTRIBUTION TO FUNCTIONAL BOWEL DISORDER

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The relationship between irritable bowel syndrome and psychiatric illness. A family study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Enteric nervous system disorders: genetic and molecular insights for the neurogastroenterologist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Irritable bowel syndrome in general practice: prevalence, characteristics, and referral

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Irritable bowel syndrome: is the search for lactose intolerance justified?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Cost-effectiveness of endoscopy in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The management of irritable bowel syndrome: a European, primary and secondary care collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Medical and lay views of irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Bran and irritable bowel syndrome: time for reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Probiotics for irritable bowel syndrome: a light in the darkness?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Serotoninergic neuroenteric modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Review article: tegaserod

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

A Randomised Controlled Trial of Psychotherapy in Patients with Refractory Irritable Bowel Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Use of hypnotherapy in gastrointestinal disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

Acupuncture treatment for irritable bowel syndrome. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909712-X

7 January 2021

10.1016/S0140-6736(02)09712-X

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12241674